Karen KATEN
Independent Director – Member of the Appointments and Governance Committee
Nationality: American
Born on August 22, 1949
Date of first appointment:May 2008
Start of current term: May 2016
End of current term: 2020(a)
(General Meeting to approve the financial statements for the fiscal year ending December 31, 2019)
Number of shares owned as of December 31, 2019: 2,425
Career
Karen Katen, a US citizen, is a graduate of the University of Chicago (BA in Political Science and MBA). In 1974, she joined Pfizer and carried out various management and executive positions during more than 30 years. In her last position with Pfizer, she was Vice-Chairman of Pfizer Inc. and President of Pfizer Human Health, the Group’s main operating department. Karen Katen played a major role in the introduction of new medicines for the treatment of cardiovascular and mental diseases, as well as diabetes and cancer. She also successfully oversaw the integration of Warner Lambert (acquired in 2000) and Pharmacia (acquired in 2003) in the Pfizer Group. Having retired from Pfizer in March 2007, she was Chairman of the Pfizer Foundation. Currently she is a Senior Advisor at Essex Woodlands Healthcare Partners, a Healthcare Venture and growth equity firm.
Positions and activities held during 2019
Functions within the Air Liquide Group
- Director: L’ Air Liquide S.A.* (member of the Appointments and Governance Committee since May 2012)
Positions or activities outside the Air Liquide Group
- Chairman of the Board: Armgo Pharma
- Chairman and Director: Rand Corporation’s Health Board of Advisors
- Director: The Economic Club of New York Board of Trustees, Peterson Institute for International Studies
- Senior Advisor: EW Health Partners
- Trustee: University of Chicago
- Trustee: University of Chicago Graduate School of Business
Jean-Paul AGON
Independent Director – Lead Director – Chairman of the Appointments and Governance Committee – Member of the Remuneration Committee
Nationality: French
Born on July 6, 1956
Date of first appointment:May 2010
Start of current term: May 2018
End of current term: 2022
(General Meeting to approve the financial statements for the fiscal year ending December 31, 2021)
Number of shares owned as of December 31, 2019: 1,784
Career
A graduate of HEC Business School, Jean-Paul Agon began his career with the L’Oréal Group in 1978. From 1981 to 1997, he held various Senior Management positions first as General Manager of L’Oréal Greece and General Manager of L’Oréal Paris, then International Managing Director for Biotherm International, Managing Director for L’Oréal Germany and finally Managing Director for L’Oréal Asia Zone. From 2001 to 2005, he was Chairman and Chief Executive Officer of L’Oréal USA as well as several subsidiaries of the L’Oréal Group in the USA. In 2005, he was appointed Deputy Chief Executive Officer of the L’Oréal Group, and became Chairman and Chief Executive Officer of the Group in 2006. He is Chairman and Chief Executive Officer of L’Oréal since March 2011.
Positions and activities held during 2019
Functions within the Air Liquide Group
- Director: L’ Air Liquide S.A.* (Lead Director since May 2017; member of the Appointments and Governance Committee since May 2015, then Chairman of this Committee since May 2017; member of the Remuneration Committee since May 2012 – Chairman of this Committee from May 2015 to May 2018)
Positions or activities outside the Air Liquide Group
- Chairman and Chief Executive Officer: L’Oréal*
- Chairman: L’Oréal Foundation
- Director: Raisesherpas
- Director: Association françaises des entreprises privées (AFEP)
- Director: Institut français des relations internationales (IFRI)
(a) Non-renewal of term in compliance with the internal regulations of the Board of Directors.